Allarity Therapeutics Inc.
Organization details
- Legal name
- Allarity Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ALLR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001860657
Board of directors
-
Gerald W. McLaughlin · DirectorSince 2025
-
Jesper Hoeiland · DirectorSince 2025
-
Joseph Walter Vazzano · DirectorSince 2023
-
Laura Benjamin · DirectorSince 2023
Director election results
Annual meeting of September 3, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.9%
-
91.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Jeremy R. Graff Officer (See Remarks) | Option exercise | +39,494 | — | — |
| Sep 30, 2026 | Jeremy R. Graff Officer (See Remarks) | Shares withheld for tax | −14,613 | $0.97 | $14,175 |
| Jan 28, 2026 | Jensen Thomas Officer (CEO) | Grant or award | +200,000 | — | — |
| Jan 28, 2026 | Gerald W. McLaughlin Director | Grant or award | +45,000 | — | — |
| Jan 28, 2026 | Jeffrey S. Ervin Officer (CFO) | Grant or award | +150,000 | — | — |
| Jan 22, 2026 | Jeremy R. Graff Officer (See Remarks) | Option exercise | +48,147 | — | — |
| Jan 22, 2026 | Jeremy R. Graff Officer (See Remarks) | Shares withheld for tax | −17,814 | $1.18 | $21,021 |
| Jan 7, 2026 | Jeremy R. Graff Officer (See Remarks) | Grant or award | +133,333 | — | — |
| Jan 7, 2026 | Jesper Hoeiland Director | Grant or award | +25,000 | — | — |
| Sep 30, 2025 | Jeremy R. Graff Officer (See Remarks) | Option exercise | +39,494 | — | — |
| Sep 30, 2025 | Jeremy R. Graff Officer (See Remarks) | Shares withheld for tax | −14,613 | $1.58 | $23,089 |
| Jan 22, 2025 | Jeremy R. Graff Officer (CDO) | Grant or award | +144,441 | — | — |
| Jan 22, 2025 | Epshinsky Alexander Officer (CFO) | Grant or award | +29,496 | — | — |
| Jan 22, 2025 | Jensen Thomas Officer (CEO) | Grant or award | +396,734 | — | — |
| Sep 30, 2024 | Jeremy R. Graff Officer (See Remarks) | Grant or award | +118,483 | $2.11 | $249,999 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Allarity Therapeutics Inc.
How many directors are on Allarity Therapeutics Inc.'s board?
Allarity Therapeutics Inc.'s board has 4 directors: Gerald W. McLaughlin, Jesper Hoeiland, Joseph Walter Vazzano and Laura Benjamin.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="allarity-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.